We serve Chemical Name:N-Butylmaleimide CAS:2973-09-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-Butylmaleimide
CAS.NO:2973-09-3
Synonyms:N-butylmaleic imide;1-Butyl-3-pyrroline-2,5-dione;N-Butylmaleinimide;1-Butyl-pyrrole-2,5-dione;N-n-Butylmaleimide;butylmaleimide;1-butyl-3-pyrroline-2,5-quinone;1-Butyl-1H-pyrrole-2,5-dione
Molecular Formula:C8H11NO2
Molecular Weight:153.17800
HS Code:2925190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:243.5ºC at 760mmHg
Density:1.12g/cm3
Index of Refraction:1.504
PSA:37.38000
Exact Mass:153.07900
LogP:0.64940
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-butylmaleic imide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Butyl-1H-pyrrole-2,5-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Butyl-pyrrole-2,5-dione Use and application,N-Butylmaleinimide technical grade,usp/ep/jp grade.
Related News: providing support for flexible, cross-sector training programmes to encourage more movement and collaboration between academia, industry and the charity sector N,N-dimethyldodecan-1-amine ethyl phosphate manufacturers It now operates fourteen plants across four continents, including two in southern California it inherited from its $112 million acquisition of German plastic packaging firm Balda in 2016. 3-[(iodoacetyl)oxy]-19-oxocarda-5,14,20(22)-trienolide suppliers SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. Peptide,(Leu-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Leu-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Lys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Leu-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Leu) vendor & factory.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. Peptide,(Leu-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Leu-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Lys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Leu-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Leu) vendor & factory.
